ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 141,46
-0,67%
Dow Jones
39 839,19
0,08%
DAX
18 726,76
-0,21%
Brent Oil
82,315
-1,45%
Bitcoin
69 838,28
-2,25%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Auris Medical Holding AG (EARS)

  7. Auris Medical Holding AG (EARS) Actualités

EARS

Auris Medical (EARS)

Auris Medical Holding AG
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:EARS
DateHeureSourceTitreSymboleSociété
27/06/202322h46Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
16/06/202323h02Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:EARSAuris Medical Holding AG
12/06/202312h44Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EARSAuris Medical Holding AG
09/06/202322h37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EARSAuris Medical Holding AG
27/04/202322h34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:EARSAuris Medical Holding AG
17/04/202318h22Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)NASDAQ:EARSAuris Medical Holding AG
13/04/202314h20Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:EARSAuris Medical Holding AG
11/04/202322h02Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:EARSAuris Medical Holding AG
11/04/202322h02Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:EARSAuris Medical Holding AG
27/03/202316h34Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:EARSAuris Medical Holding AG
23/09/202222h32Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:EARSAuris Medical Holding AG
14/04/202222h53Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:EARSAuris Medical Holding AG
12/04/202214h02Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:EARSAuris Medical Holding AG
08/12/202122h38Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:EARSAuris Medical Holding AG
16/07/202115h00GlobeNewswire Inc.Auris Medical Announces Launch of New Corporate WebsiteNASDAQ:EARSAuris Medical Holding AG
14/07/202115h00GlobeNewswire Inc.Auris Medical Announces Publication of Data from Preclinical Studies with Bentrio™ Nasal Spray in Prevention and Mitigation...NASDAQ:EARSAuris Medical Holding AG
06/07/202115h00GlobeNewswire Inc.Auris Medical to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore™...NASDAQ:EARSAuris Medical Holding AG
28/06/202114h30GlobeNewswire Inc.Auris Medical to Initiate Market Launch of Bentrio™ Nasal Spray in GermanyNASDAQ:EARSAuris Medical Holding AG
21/06/202114h30GlobeNewswire Inc.Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adul...NASDAQ:EARSAuris Medical Holding AG
03/06/202113h30GlobeNewswire Inc.Auris Medical Announces Acquisition of RNA Therapeutics Company and Plans for Strategic RepositioningNASDAQ:EARSAuris Medical Holding AG
01/06/202114h30GlobeNewswire Inc.Auris Medical Starts Preparations for Covid-19 Trial with Bentrio in IndiaNASDAQ:EARSAuris Medical Holding AG
28/05/202114h30GlobeNewswire Inc.Auris Medical Holding to Present at LD Micro Invitational XI ConferenceNASDAQ:EARSAuris Medical Holding AG
25/05/202115h00GlobeNewswire Inc.Auris Medical Announces Completion of Bentrio Conformity Assessment Procedure for Marketing in EUNASDAQ:EARSAuris Medical Holding AG
14/05/202114h30GlobeNewswire Inc.Auris Medical Reaches Midpoint for Enrollment in Part B of AM-125 Phase 2 TRAVERS Trial in Acute Peripheral VertigoNASDAQ:EARSAuris Medical Holding AG
07/05/202115h05GlobeNewswire Inc.Auris Medical Provides Update on Bentrio Program in AllergyNASDAQ:EARSAuris Medical Holding AG
13/04/202113h45GlobeNewswire Inc.Auris Medical Announces Positive Preclinical and Clinical Outcomes with AM-301 and Details Plans for Market LaunchNASDAQ:EARSAuris Medical Holding AG
08/04/202114h00GlobeNewswire Inc.Auris Medical to Provide Business Update on AM-301 Program on Tuesday, April 13, 2021NASDAQ:EARSAuris Medical Holding AG
31/03/202114h30GlobeNewswire Inc.Auris Medical Provides Business Update and Reports Second Half and Full Year 2020 Financial ResultsNASDAQ:EARSAuris Medical Holding AG
24/03/202113h00GlobeNewswire Inc.Auris Medical to Report Second Half and Full Year 2020 Financial Results and Provide Business Update on Wednesday, March 31, ...NASDAQ:EARSAuris Medical Holding AG
29/01/202114h30GlobeNewswire Inc.Auris Medical Announces Initiation of Clinical Investigation of AM-301 in Allergic RhinitisNASDAQ:EARSAuris Medical Holding AG
 Showing the most relevant articles for your search:NASDAQ:EARS

Dernières Valeurs Consultées

EU
XS1808739459
ABN AMRO Bank 0.875% 22a...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés